Proton nanomodulators for enhanced Mn2+-mediated chemodynamic therapy of tumors via HCO3− regulation

Peng Yang,Shaojie Liu,Zhuang Chen,Weijing Liu,Deshang Duan,Zuo Yang,Haohao Yan,Zhiping Rao,Xianghan Zhang,Ruili Zhang,Zhongliang Wang
DOI: https://doi.org/10.1186/s12951-024-02843-4
IF: 10.2
2024-11-03
Journal of Nanobiotechnology
Abstract:Mn 2+ -mediated chemodynamic therapy (CDT) has been emerged as a promising cancer therapeutic modality that relies heavily on HCO 3 − level in the system. Although the physiological buffers (H 2 CO 3 /HCO 3 − ) provide certain amounts of HCO 3 − , the acidity of the tumor microenvironment (TME) would seriously affect the HCO 3 − ionic equilibrium (H 2 CO 3 ⇌ H + + HCO 3 − ). As a result, HCO 3 − level in the tumor region is actually insufficient to support effective Mn 2+ -mediated CDT.
biotechnology & applied microbiology,nanoscience & nanotechnology
What problem does this paper attempt to address?